Chief, #Cardiology at @NorthwesternMed @NMCardioVasc. Magerstadt Professor of Medicine, Vice-Dean, Health Equity @NUFeinbergMed. Past President @American_Heart
📉⚡ Early + complete GDMT = best outcomes
The four pillars work fast 🚀 and work best together 🛡️
Simultaneous/rapid sequencing to all four components of quadruple GDMT at 🎯 doses (as well tolerated) should be the standard of care for all
❤️🩹 #GDMT#HeartFailure https://t.co/LvqP2YmHWe
“We really want to ensure that our patients are getting met where they live and getting the care that they deserve in their own neighborhoods,” says Palak Shah, MD.
On Better Edge, Dr. Shah shares his vision to expand access to advanced heart failure care across the Chicago area. Listen here: https://t.co/iBttlvh7im
Heart failure with preserved ejection fraction has nuanced pathways for diagnosis, management and long-term care. In a recent Medical Stories feature, Clyde W. Yancy, MD, MSc (@NMHheartdoc), and Jane E. Wilcox, MD, MSc (@WilcoxHeart), provide clinical perspective on sex-specific prevalence, disease progression and the importance of individualized management strategies.
Watch here: https://t.co/p0PHRE0uaL
In @theNAMedicine, Northwestern Medicine cardiologists Clyde W. Yancy, MD, MSc (@NMHheartdoc), and Nilay S. Shah, MD, MPH (@NilayShahMDMPH), share that earlier assessment, personalized low-density lipoprotein targets, and broader risk evaluation support a more complete approach to preventing cardiovascular disease in patients: https://t.co/WczTuqo8Mw
Reminder! Join us on Monday, July 20, 2026, from 9:30-10:30 am ET for Baim Grand Rounds with @scottdsolomon, presenting “Heart Failure with Mildly Reduced or Preserved Ejection Fraction – the Long and Winding Road.” Zoom link: https://t.co/qnyjWFye6B
ACC, AHA, ESC & World Heart Federation call for a new era of equity-centered CV care. A new #JACC editorial outlines 7 priorities to advance #HealthEquity science and ensure all patients benefit from modern cardiovascular medicine. https://t.co/ttw5At2TVZ #CVD#cvPrev
Myth: most patients newly presenting with HFrEF can't tolerate simultaneous, polypill, or rapid-sequence quadruple GDMT because of dangerous hypotension risk
At the Women’s Heart Care Panel, our cardiologists Jane E. Wilcox, MD, MSc (@WilcoxHeart), Priya M. Freaney, MD (@PriyaFreaneyMD), Sarah A. Goldstein, MD (@sgolds13), Ranya N. Sweis, MD, MS (@DrRanyaSweis), Linda Lee, MD (@Linda_Lee_MD), and Clyde W. Yancy, MD, MSc (@NMHheartDoc), shared their clinical insight on cardiovascular risk across a woman’s lifespan, including menopause, treatment considerations and prevention.
Our physicians connect with our community to support informed, proactive approaches to women’s cardiovascular health.
The recording from yesterday’s Grand Rounds with @NMHheartdoc titled “Health Equity: Current Status and Future Approaches” is now available on the Baim website. You can find it here: https://t.co/CxzhatTyJG
Last night we celebrated the incredible leaders and organizations making an extraordinary impact on the @American_Heart mission during our annual National Volunteer Awards event. This year’s honorees exemplify what it means to take bold action, meet people where they are, and remain relentless in the pursuit of longer, healthier lives for all. Please join me in applauding this extraordinary group of honorees whose service and vision are nothing short of lifesaving.
Read their inspiring stories: https://t.co/kFQO95IB1m
#NVA2026
💔 Patient with HF 🏨 for worsening
✅ SGLT2i Rx with in-🏨 initiation, 1st 60 days
☠️ ⬇️ by 39%
RR 0.61, 95% CI 0.47-0.81, p=0.0005
ARR 2.4% fewer ☠️s (95% CI 3.3%-1.2%)
Safe, no net ⬆️ AEs
💊 Cost $10 (dapagliflozin 10 mg)
https://t.co/FaKkMGii8P
💊 ARNI for HFrEF
❤️🩹 Benefits>>>potential risks
⏱️ Rapid ⬇️ events
🥇First line over ACEI or ARB
⚖️ High value
🔰No significant heterogeneity of treatment effects
🎯 The most precision guided and personalized approach to use:
✅ Treat all eligible individuals w/o CIs
In Northwestern Medicine Heart Conversations episode 7, Clyde W. Yancy, MD, MSc, (@NMHheartdoc), and Jane E. Wilcox, MD, MSc, (@WilcoxHeart), are joined by Priya M. Freaney, MD, @PriyaFreaneyMD), and Sarah A. Goldstein, MD, (@sgolds13), to discuss cardiovascular risk during pregnancy and menopause, as well as sex specific statin management.
Listen to the full conversation here:
https://t.co/LhXu92CMNq
Shout out to @JTWilkinsMD who joined the @TODAYshow to discuss how individuals should adjust habits to better take care of their cholesterol health.
Read Here: https://t.co/hrWnJw3S1T